Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiencies (PID)”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Large-scale testing (Phase 3)Study completedNCT01199705
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 25
Not applicableStudy completedNCT04636502
What this trial is testing

Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiencies (PID)
Shire 96
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Large-scale testing (Phase 3)Looking for participantsNCT07346859
What this trial is testing

Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency Diseases
Biopharma Plasma LLC 56
Large-scale testing (Phase 3)Study completedNCT00751621
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

Who this might be right for
Primary Immunodeficiency (PID)
CSL Behring 40
Testing effectiveness (Phase 2)Study completedNCT00161993
What this trial is testing

Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)

Who this might be right for
Primary Immunodeficiency Diseases (PID)AgammaglobulinemiaHypogammaglobulinemia
Baxalta now part of Shire 24
Large-scale testing (Phase 3)Study completedNCT00546871
What this trial is testing

Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 49
Not applicableStudy completedNCT05621876
What this trial is testing

Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia

Who this might be right for
Primary Immunodeficiency Diseases
PATH 50
Large-scale testing (Phase 3)Study completedNCT04842643
What this trial is testing

An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

Who this might be right for
Primary Immunodeficiency Disease
Takeda 12
Large-scale testing (Phase 3)Study completedNCT00322556
What this trial is testing

Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 55
Not applicableUnknownNCT03668288
What this trial is testing

Tolerance and Patients' Satisfaction With IGHy

Who this might be right for
Secondary or Primary Immunodeficiency
CHU de Reims 20
Testing effectiveness (Phase 2)Looking for participantsNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Large-scale testing (Phase 3)Not Yet RecruitingNCT07017036
What this trial is testing

Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Virchow Group 44
Large-scale testing (Phase 3)Study completedNCT01485796
What this trial is testing

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 54
Not applicableUnknownNCT03037359
What this trial is testing

A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products

Who this might be right for
Primary Immune Deficiency Disorder
ADMA Biologics, Inc. 200
Not applicableUnknownNCT04572620
What this trial is testing

Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.

Who this might be right for
Interstitial Lymphocytic Lung Disease
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Large-scale testing (Phase 3)Study completedNCT00814320
What this trial is testing

Gammagard Liquid and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 89
Not applicableUnknownNCT03252548
What this trial is testing

Pediatric Primary Immunodeficiency Disease (PID) in China

Who this might be right for
Primary Immunodeficiency Disease
Beijing Children's Hospital 400
Not applicableStudy completedNCT03339778
What this trial is testing

The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations

Who this might be right for
Primary Immunodeficiency
IMMUNOe Research Centers 15
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Load More Results
190